Vicapsys Life Sciences, Inc. (VICP)
1.45
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Vicapsys Life Sciences Cash from Operations (Quarterly) : -0.0051M for March 31, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0051M |
| March 31, 2025 | -0.0057M |
| December 31, 2024 | -0.078M |
| September 30, 2024 | -0.0404M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | -0.0033M |
| December 31, 2023 | 0.0206M |
| September 30, 2023 | -0.1596M |
| June 30, 2023 | -0.2181M |
| March 31, 2023 | -0.01M |
| December 31, 2022 | 0.0029M |
| September 30, 2022 | -0.0411M |
| June 30, 2022 | -0.084M |
| March 31, 2022 | -0.116M |
| December 31, 2021 | -0.1233M |
| September 30, 2021 | -0.1801M |
| June 30, 2021 | -0.0698M |
| March 31, 2021 | -0.0708M |
| December 31, 2020 | -0.0004M |
| September 30, 2020 | -0.0033M |
| June 30, 2020 | -0.026M |
| March 31, 2020 | -0.2332M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 |
| Date | Value |
|---|---|
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.28M |
| Sarepta Therapeutics, Inc. | 197.07M |
| Anixa Biosciences, Inc. | -1.741M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.135M |
| Free Cash Flow | -0.1292M |
| Free Cash Flow Per Share (Quarterly) | -0.0001 |
| Free Cash Flow to Equity (Quarterly) | -0.0504M |
| Free Cash Flow to Firm (Quarterly) | 0.0031M |
| Free Cash Flow Yield | -0.26% |